Literature DB >> 24065530

Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study.

Veronika Polakova Vymetalkova1, Luca Vannucci, Vlasta Korenkova, Pavel Prochazka, Jana Slyskova, Ludmila Vodickova, Vendula Rusnakova, Ludovit Bielik, Monika Burocziova, Pavel Rossmann, Pavel Vodicka.   

Abstract

Altered expression and methylation pattern of tumor suppressor and DNA repair genes, in particular involved in mismatch repair (MMR) pathway, frequently occur in primary colorectal (CRC) tumors. However, little is known about (epi)genetic changes of these genes in precancerous and early stages of CRC. The aim of this pilot study was to analyze expression profile and promoter methylation status of important tumor suppressor and DNA repair genes in the early stages of experimentally induced colorectal carcinogenesis. Rats were treated with azoxymethane (AOM), dextran sodium sulphate (DSS) or with their combination, and sacrificed 1 or 4 months post-treatment period. The down-regulation of Apc expression in left colon, detectable in animals treated with DSS-AOM and sacrificed 1 month after the end of treatment, represents most early marker of the experimental colorectal carcinogenesis. Significantly reduced gene expressions were also found in 5 out of 7 studied MMR genes (Mlh1, Mlh3, Msh3 Pms1, Pms2), regarding the sequential administration of DSS-AOM at 4 months since the treatment. Strong down-regulation was also discovered for Apc, Apex1, Mgmt and TP53. Tumors developed in rectum-sigmoid region displayed significantly lower Apc and Pms2 expressions. The decreased expression of studied genes was not in any case associated with aberrant methylation of promoter region. Present data suggest that down-regulation of Apc and MMR genes are prerequisite for the development of CRC. In this study we addressed for the first time early functional alterations of tumor suppressor genes with underlying epigenetic mechanisms in experimentally induced CRC in rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065530     DOI: 10.1007/s11033-013-2699-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

1.  The many ways to open the gate to colon cancer.

Authors:  James M Amos-Landgraf; Linda Clipson; Michael A Newton; William F Dove
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

2.  Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease.

Authors:  Z Lin; J P Hegarty; J A Cappel; W Yu; X Chen; P Faber; Y Wang; A A Kelly; L S Poritz; B Z Peterson; S Schreiber; J-B Fan; W A Koltun
Journal:  Clin Genet       Date:  2010-10-18       Impact factor: 4.438

3.  Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.

Authors:  Mev Dominguez Valentin; Felipe Carneiro da Silva; Erika Maria Monteiro dos Santos; Bianca Garcia Lisboa; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Israel Gomy; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mariana Redal; Carlos Vaccaro; Adriana Della Valle; Carlos Sarroca; Dirce Maria Carraro; Benedito Mauro Rossi
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

4.  CpG island methylation in colorectal adenomas.

Authors:  A Rashid; L Shen; J S Morris; J P Issa; S R Hamilton
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Expression Profiles in Stage II Colon Cancer According to APC Gene Status.

Authors:  David J Birnbaum; Sophy Laibe; Anthony Ferrari; Arnaud Lagarde; Aurélie J Fabre; Geneviève Monges; Daniel Birnbaum; Sylviane Olschwang
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

Review 6.  Epigenetics and cancer treatment.

Authors:  Lasse Sommer Kristensen; Helene Myrtue Nielsen; Lise Lotte Hansen
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

7.  Organ-specific carcinogenesis in rats by methyl- and ethylazoxyalkanes.

Authors:  W Lijinsky; J E Saavedra; M D Reuber
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

8.  Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.

Authors:  Kosuke Hosoya; Satoshi Yamashita; Takayuki Ando; Takeshi Nakajima; Fumio Itoh; Toshikazu Ushijima
Journal:  Cancer Lett       Date:  2009-06-13       Impact factor: 8.679

9.  Enteric bacteria and cancer stem cells.

Authors:  Jun Sun
Journal:  Cancers (Basel)       Date:  2010       Impact factor: 6.639

10.  DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients.

Authors:  Torbjörn K Nilsson; Zarah M Löf-Öhlin; Xiao-Feng Sun
Journal:  Int J Oncol       Date:  2012-10-30       Impact factor: 5.650

View more
  1 in total

1.  DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.

Authors:  Yin Sun; Shu Li; Keng Shen; Shuang Ye; Dongyan Cao; Jiaxin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.